title: Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.
abstract: Approximately 3 million patients with symptoms suggestive of obstructive coronary artery disease (CAD) present to primary care offices in the United States annually, resulting in approximately $6.7 billion in cardiac workup costs. Despite wide application of existing diagnostic technologies, yield of obstructive CAD at invasive coronary angiography (ICA) is low. This study used a decision analysis model to assess the economic utility of a novel gene expression score (GES) for the diagnosis of obstructive CAD. Within a representative commercial health plan's adult membership, current practice for obstructive CAD diagnosis (usual care) was compared to a strategy that incorporates the GES test (GES-directed care). The model projected the number of diagnostic tests and procedures performed, the number of patients receiving medical therapy, type I and type II errors for each strategy of obstructive CAD diagnosis, and the associated costs over a 1-year time horizon. Results demonstrate that GES-directed care to exclude the diagnosis of obstructive CAD prior to myocardial perfusion imaging may yield savings to health plans relative to usual care by reducing utilization of noninvasive and invasive cardiac imaging procedures and increasing diagnostic yield at ICA. At a 50% capture rate of eligible patients in GES-directed care, it is projected that a commercial health plan will realize savings of $0.77 per member per month; savings increase proportionally to the GES capture rate. These findings illustrate the potential value of this new blood-based, molecular diagnostic test for health plans and patients in an age of greater emphasis on personalized medicine.
authors.affiliation: 1 St John's Medical Center , Jackson, Wyoming.
authors.forename: Louis I
authors.initials: LI
authors.lastname: Hochheiser
authors.forename: Jessie L
authors.initials: JL
authors.lastname: Juusola
authors.forename: Mark
authors.initials: M
authors.lastname: Monane
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Ladapo
mesh_terms: D000328:Adult; D057791:Cardiac Imaging Techniques / Q000191:economics; D003324:Coronary Artery Disease / Q000150:complications / Q000175:diagnosis* / Q000235:genetics*; D003661:Decision Support Techniques; D005260:Female; D015870:Gene Expression; D005820:Genetic Testing / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity